NCT05319886 2022-05-20
AP
The First Affiliated Hospital of Xinxiang Medical College
Unknown
Clinical Trials
6 trialsNCT04731909 2021-02-10
Toripalimab Combined With Anlotinib, Etoposide and Platinum in the Treatment of Extensive-stage Small Cell Lung Cancer
Third Military Medical University
Phase NA Unknown
NCT03983928 2019-08-15
Study of TQB2450 Combined With Anlotinib in the Treatment of Mutation Positive Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2 Unknown
NCT03780283 2018-12-21
Efficacy and Safety of Anlotinib as Maintenance Treatment After First-line Chemotherapy in SCLC
First Hospital of Shijiazhuang City
Phase 2 Unknown
NCT03765775 2018-12-06
Anlotinib Plus Sintilimab for NSCLC Patients With First-generation EGFR-TKIs Drug Resistance Along With T790M Negative
First Hospital of Shijiazhuang City
Phase 2 Unknown
NCT03589950 2018-07-18
Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung Cancer
The First People's Hospital of Lianyungang
Phase 2 Unknown